{
  "pmcid": "12322986",
  "sha256": "b05cf592129765180cc9339a595bc68a9ac9b3121538a47300972bf8a5cd99b8",
  "timestamp_utc": "2025-11-09T23:33:14.654122+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.390123329907503,
    "reading_ease": 36.979628297362126,
    "word_count": 278
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Neoadjuvant PD-1 Blockade Plus Chemoradiotherapy in Pancreatic Ductal Adenocarcinoma"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were divided into a combined group receiving PD-1 blockade plus chemoradiotherapy and a non-combined group receiving PD-1 blockade plus chemotherapy."
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted at Nanjing Drum Tower Hospital, China, this retrospective cohort study included PDAC patients undergoing resection after neoadjuvant treatment (NAT)."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were divided into a combined group receiving PD-1 blockade plus chemoradiotherapy and a non-combined group receiving PD-1 blockade plus chemotherapy."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to assess the impact of neoadjuvant PD-1 blockade plus chemoradiotherapy on pathological response (PR) and survival in pancreatic ductal adenocarcinoma (PDAC)."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was complete pathological response (CPR), assessed using the CAP and MDACC systems."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 47 patients were enrolled, with 26 in the combined group and 21 in the non-combined group."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "A total of 47 patients were enrolled, with 26 in the combined group and 21 in the non-combined group."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "CPR was achieved in 6 patients (23.1%) in the combined group and none in the non-combined group."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "The study was not registered"
      },
      "Funding": {
        "score": 0,
        "evidence": "funding details were not provided"
      }
    },
    "total_score": 13,
    "max_score": 25
  }
}